Bulletin du Cancer Journal Citation Rate 2026
0007-4551
eISSN 1769-6917
Elsevier BV
FR
Q3 Quartile
About Bulletin du Cancer
Bulletin du Cancer (BDC) is a peer-reviewed academic journal covering Cancer Immunotherapy and Biomarkers and Cancer Treatment and Pharmacology, published by Elsevier BV in FR, catalogued under ISSN 0007-4551 (e-ISSN 1769-6917). As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 0.34 (Q3 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It operates a subscription model (APC ~$1790 USD).
Bulletin du Cancer Citation Rate 2026 — In Context
Bulletin du Cancer has a 2025 2-Year Citation Rate (OpenAlex) of 0.34, placing it in the Q3 quartile within the Cancer Immunotherapy and Biomarkers research area. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.
Bulletin du Cancer operates a subscription-based publishing model — readers access articles through institutional subscriptions or pay-per-view.
Researchers looking to publish in Bulletin du Cancer should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare Bulletin du Cancer against similar journals in the field, use our journal comparison tool.
Submission Tips for Bulletin du Cancer
- Budget $1790 for the Article Processing Charge. Check if your institution or funder covers OA fees.
- This journal covers Cancer Immunotherapy and Biomarkers, Cancer Treatment and Pharmacology, Colorectal Cancer Treatments and Studies. Ensure your manuscript aligns with these scope areas to avoid desk rejection.
How Bulletin du Cancer Compares
Compared against 8 journals in the same research areas.
| ISSN (Print) | 0007-4551 |
|---|---|
| ISSN (Online) | 1769-6917 |
| Publisher | Elsevier BV |
| Country | France |
| APC / Cost | $1790 USD |
In-depth profile & metrics
Bulletin du Cancer is published by Elsevier BV and based in France. It runs on a subscription or hybrid model with an article-processing charge of USD 1790.
In our subject taxonomy, Bulletin du Cancer is classified under Cancer Immunotherapy and Biomarkers, Cancer Treatment and Pharmacology, Colorectal Cancer Treatments and Studies and Health, Medicine and Society.
Bulletin du Cancer is indexed in OpenAlex. OpenAlex tracking provides an open, citable record of its output even where commercial indexing is absent.
Its most recent citation rate stands at 0.336.
Research Areas
Links
Continue on JournalsHub
Put what you just read into practice with these free tools.
Frequently Asked Questions about Bulletin du Cancer
Live Indexing Status
Updated April 2026Track real-time indexing metrics to ensure this journal meets your academic requirements.
Citation Rate
Historical Trend
Initial data points onlyCitation Rate by Year
| Year | Value | Source |
|---|---|---|
| 2025 | 0.336 | 2-Year Mean Citedness (OpenAlex) |
Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.
Compare Journals
Compare Bulletin du Cancer against similar publications in its field:
Related Journals in Your Field
-
BMJ Oncology BMJ IF 4.52
-
Clinical & Translational Oncology Springer Science+Business Media IF 2.27
-
International Journal of General Medicine Dove Medical Press IF 1.96
-
Discover Oncology Springer Nature IF 1.83
-
Cancer Research American Association for Cancer Research IF 0.46
Explore More Journals
Metadata
Last updated: Apr 24, 2026
Updated by: openalex_bulk
OpenAlex ID: S22998730
Get weekly updates for Cancer Immunotherapy and Biomarkers journals
Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.